drugset / Trial / NCT03502434

A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers

NCT03502434 ↗

Phase 1 Completed 223 enrolled Biosplice Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a single center, randomized, controlled, within subject comparison, single dose study to determine the sensitization potential of SM04755 solution on normal skin under semi-occlusive patch conditions.

Timeline

Start
2017-09-11
Primary completion
2017-11-17
Completion
2017-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject SM04755 Small molecule 90 mg/ml Topical

Indications